3D Positioning Platform
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95020Q00076 and the solicitation is issued as a Request for Quotation (RFQ) on a competitive basis, set aside to small businesses under the applicable NAICS. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5—Test Program for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items. This acquisition is NOT expected to exceed the simplified acquisition teshold of $250,000.00. A Fixed-Price type of contract is contemplated for any resulting contract entered into as a result of this solicitation. (iii) The solicitation document and incorporated provisions and clauses are those in effect tough Federal Acquisition Regulation (FAR) Federal Acquisition Circular (FAC) Number/Effective Date: 2020-06 / 05-06-2020. (iv) The North American Industry Classification System (NAICS) code for this procurement is 333912-333912 - Air and Gas Compressor Manufacturing with a size standard 1000 employees. A Total Set-Aside restriction to Small Business is applicable. (v) The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The National Center for Advancing Translational Sciences (NCATS) is a translational science center whose mission is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. NCATS experts are applying the techniques of 3-D bioprinting to develop tissue models that mimic the organization and physiology of cells in the tissues of living organisms, in a microplate format for drug screening. The NCATS 3D Tissue Bioprinting Lab has a potential requirement for a versatile XYZ platform with a custom automated microelectrode arm to hold one or two microelectrode holders. This potential requirement will fit with the software and the sensor that can measure dopamine neurotransmitters and shall be a versatile XYZ platform that can be used to meet very fine tolerances in the um range for a variety of electrophysiology and optogenetic measurements. This will require integrated XYZ control coupled with coordinated signal acquisition and generation depending upon the required sensors in question. The platform needs to also be customizable both from a hardware and software perspective for proper configuration adjustment. (vi) The purpose of this requirement is to obtain one (1) 3D Positioning Platform unit on a Brand-Name-or-Equal basis to the Cetoni neMAXYS 200 - 3D positioning platform as described and identified herein manufactured by Cetoni GmbH, located at Wiesenring 6, 07554 Korbussen, Germany. The neMAXYS 200 - 3D positioning platform will provide NCATS scientists the ability to perform the measurements expected with acceptable accuracy, precision and repeatability. The instrument uniquely combines advanced technical features meeting current NCATS’ 3D bioprinting, data acquisition and analysis software needs. Specifically, this requirement shall provide, on a brand name or equal basis, the following manufacturer part number, part name and quantity: A3928000006 – neMAXYS 200 - 3D positioning platform (movement range XY/Z: 544 x 494 / 506 mm, dimensions LWH: 470x480x488 mm, with universal tool [Z] and sample holders [XY], power supply plus USB and RS232 cables) T6000000014 – Qmix SDK 32bit/64bit - Software Development Kit (Windows DLLs, LabVIEW Kit, incl. documentation, programming examples) A2033000144 – Qmix I/O-B module - custom module for implementation of up to 15 Beckhoff I/O KLXXXX bus terminals B5A02000037 – terminal clamp KL1408, digital input 8x DI 8x(L:-3-5V H:11-30V) B5A02000008 – terminal clamp KL2408, digital output 8x DO 8x(0/24V 0,5A) B3720000067 – terminal clamp KL9505, 5V output (0.5A) Ue:24VDC Ua:5V 0,5A B3720000062 – terminal clamp KL3162, 2-channel 16 bit analog input terminal KL3162, 0…10 V, wired, precision 0,05% 2x analog Input 0…10 V, 16bit B5A02000035 – terminal clamp KL3468, 8-channel analog input terminal 0…10 V AI 8x(0..10V) 12Bit B5A02000074 – Potential distribution terminal KL9185 4xVCC 4xGND (von Schiene) B5A02000062 – terminal clamp KL4404, analog out 4x AO 4x(0..10 V) 12 bit B5A02000054 – 4-channel digital input terminal 5 V DC - KL1124 DI 4x(L:0-0,8V H:2,4-5V) B5A02000055 – 4-channel digital output terminal 5 V DC, 20 (8) mA 5 V DC - KL2124 A2030000033 – Z-Axis for neMAXYS 200 (2) Products offered must include those salient physical, functional, or other characteristics that are deemed essential in meeting the government’s needs. Specifically, the following features are deemed the salient characteristics that this requirement shall achieve: -Must have XY-system with additional z-axis for movements with micrometer accuracy -Must be able to use multiple different interfaces (USB, CAN, RS232, trigger interface) -Must be able to be expanded with other Qmix modules (I/O, heater, controller, pumps) -Need traversing range: 200 x 200 x 50 mm -Must have a max. speed: 200 / 200 / 70 mm/s Offerors submitting a quotation must: 1) clearly indicate if the line item or items being offered in their quote is a brand-name item to the brand name item described in this solicitation, or if the item or items being offered is an “or-equal” item; 2) include Shipping and handling cost in the quotation as a separate line item, or specify if it is included in the total price; 3) indicate an estimated delivery time in full after receipt of an order; 4) indicate if items being quoted are warrantied in accordance with Offeror’s standard commercial warranty practices, and/or whether software support is included and the length of time of such warranty/support subscription, and/or if extended years of service coverage are available or applicable in accordance with the manufacturer’s standard commercial item practice. (vii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated DELIVERY DATE after receipt of order (ARO) shall be specified in the offeror’s quote and will be determined prior to any award. Delivery will be FOB - DESTINATION. The place of delivery and acceptance will be 9800 Medical Center Drive, Rockville, MD 20850. (viii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: • FAR 52.204-7, System for Award Management (Oct 2018) • FAR 52.204-16, Commercial and Government Entity Code Reporting (Jul 2016) • FAR 52.211-6, Brand Name or Equal (Aug 1999) • FAR 52.212-1, Instructions to Offerors-Commercial Items (Oct 2018) • FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (Oct 2018) • HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: • FAR 52.204-13, System for Award Management Maintenance (Oct 2018) • FAR 52.204-18, Commercial and Government Entity Code Maintenance (Jul 2016) • FAR 52.212-4, Contract Terms and Conditions--Commercial Items (Oct 2018) • FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019) • FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019) The provisions of FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items (May 2019) is applicable to this solicitation: 52.219-6 Notice of Total Small Business Set-Aside (Nov 2011) 52.219-13 Notice of Set-Aside of Orders (Nov 2011) 52.222-3 Convict Labor (June 2003) 52.222-19 Child Labor-Cooperation With Authorities and Remedies (Jan 2018) 52.222-21 Prohibition of Segregated Facilities (Apr 2015) 52.222-26 Equal Opportunity (Sep 2016) 52.222-36 Equal Opportunity for Workers with Disabilities (Jul 2014) 52.222-50 Combating Trafficking in Persons (Jan 2019) 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving (Aug 2011) 52.225-13 Restriction on Certain Foreign Purchases (Jun 2008) 52.232-33 Payment by Electronic Funds Transfer-- System for Award Management (Oct 2018) The following provisions and clauses apply to this acquisition and are incorporated as an attachment: • NIH Invoice and Payment Provisions (2/2014) (ix) The Government will evaluate quotations or offers in accordance with FAR 13.106-2 and award a purchase order from this solicitation to the responsible offeror whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotes: a. Technical capability of the item offered to meet the Government requirement; b. Price; and c. Past performance [see FAR 13.106-2(b)(3)]. Respondents that believe that they are manufacturers or authorized resellers of any BRAND-NAME product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. (xi) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. (xii) The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition and is incorporated in full text. (xiii) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xiv) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xv) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. The Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov and the offeror representation in FAR Provision 52.204-24, which is attached, MUST be completed and submitted with any quotation or response to this RFQ. (xvi) All responses must be received no later than the date specified in this announcement. Late responses will not be accepted. All responses must reference the subject solicitation number. Responses must be submitted electronically to hunter.tjugum@nih.gov. Facsimile responses will not be accepted. For information regarding this solicitation, contact Hunter Tjugum by email at hunter.tjugum@nih.gov or by phone at 301-827-5304.
75N95020Q00076 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
5/7/20, 5:25 PM 3D Positioning Platform
INTRODUCTION This is a Small Business Sources Sought (SBSS) notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. This notice is issued to help determine the availability and type of qualified Small Business companies technically capable of meeting this potential government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. The notice is strictly for research and information purposes only. The information requested will assist the Government in determining the appropriate acquisition method including small business socio-economic set-aside possibilities and to determine the availability of qualified Small Business companies technically capable of meeting the Government’s potential requirement. All Small Business companies with the capability and availability to perform the requirement under the applicable NAICS code are invited to submit a response to this notice. NORTH AMERICAN CLASSIFICATION SYSTEM (NAICS) CODE The NAICS code applicable to this requirement is 334516 - Analytical Laboratory Instrument Manufacturing with size standard 1000 employees. BACKGROUND The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The National Center for Advancing Translational Sciences (NCATS) is a translational science center whose mission is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. NCATS experts are applying the techniques of 3-D bioprinting to develop tissue models that mimic the organization and physiology of cells in the tissues of living organisms, in a microplate format for drug screening. The NCATS 3D Tissue Bioprinting Lab has a potential requirement for a versatile XYZ platform with a custom automated microelectrode arm to hold one or two microelectrode holders. This potential requirement will fit with the software and the sensor that can measure dopamine neurotransmitters and shall be a versatile XYZ platform that can be used to meet very fine tolerances in the um range for a variety of electrophysiology and optogenetic measurements. This will require integrated XYZ control coupled with coordinated signal acquisition and generation depending upon the required sensors in question. The platform needs to also be customizable both from a hardware and software perspective fro configuration adjustment. Purpose and Objectives The purpose of this potential acquisition is to obtain one (1) 3D Positioning Platform unit on a Brand-Name-or-Equal basis to the Cetoni neMAXYS 200 - 3D positioning platform as described and identified herein manufactured by Cetoni GmbH, located at Wiesenring 6, 07554 Korbussen, Germany. The neMAXYS 200 - 3D positioning platform will provide NCATS scientists the ability to perform the measurements expected with acceptable accuracy, precision and repeatability. The instrument uniquely combines advanced technical features meeting current NCATS’ 3D bioprinting, data acquisition and analysis software needs. Project Requirements Offerors submitting a response to this Small Business Sources Sought notice shall possess the ability to achieve the essential government features specified herein. Products offered must include those salient physical, functional, or other characteristics of the items identified in this notice that are manufactured by Centoni GmBH and deemed essential in meeting the government’s needs. Specifically, the following are considered essential characteristics of this potential requirement, or its equal: -Must have XY-system with additional z-axis for movements with micrometer accuracy -Must be able to use multiple different interfaces (USB, CAN, RS232, trigger interface) -Must be able to be expanded with other Qmix modules (I/O, heater, controller, pumps) -Need traversing range: 200 x 200 x 50 mm -Must have a max. speed: 200 / 200 / 70 mm/s Products offered must be essentially equal to the supply described in this solicitation, which specifically includes the following manufacturer part number, part name and quantity: A3928000006 – neMAXYS 200 - 3D positioning platform (movement range XY/Z: 544 x 494 / 506 mm, dimensions LWH: 470x480x488 mm, with universal tool [Z] and sample holders [XY], power supply plus USB and RS232 cables) T6000000014 – Qmix SDK 32bit/64bit - Software Development Kit (Windows DLLs, LabVIEW Kit, incl. documentation, programming examples) A2033000144 – Qmix I/O-B module - custom module for implementation of up to 15 Beckhoff I/O KLXXXX bus terminals B5A02000037 – terminal clamp KL1408, digital input 8x DI 8x(L:-3-5V H:11-30V) B5A02000008 – terminal clamp KL2408, digital output 8x DO 8x(0/24V 0,5A) B3720000067 – terminal clamp KL9505, 5V output (0.5A) Ue:24VDC Ua:5V 0,5A B3720000062 – terminal clamp KL3162, 2-channel 16 bit analog input terminal KL3162, 0…10 V, wired, precision 0,05% 2x analog Input 0…10 V, 16bit B5A02000035 – terminal clamp KL3468, 8-channel analog input terminal 0…10 V AI 8x(0..10V) 12Bit B5A02000074 – Potential distribution terminal KL9185 4xVCC 4xGND (von Schiene) B5A02000062 – terminal clamp KL4404, analog out 4x AO 4x(0..10 V) 12 bit B5A02000054 – 4-channel digital input terminal 5 V DC - KL1124 DI 4x(L:0-0,8V H:2,4-5V) B5A02000055 – 4-channel digital output terminal 5 V DC, 20 (8) mA 5 V DC - KL2124 A2030000033 – Z-Axis for neMAXYS 200 (2) Contractors submitting a response to this Small Business Sources Sought notice shall possess the ability to achieve the salient government essential features of this potential requirement. Specifically, Offerors to this Small Business Sources Sought notice shall document evidence of being able to provide the subject supply that will allow for the essential features described herein to be accomplished. Delivery/Warranty Offerors must indicate an estimated delivery time in full after receipt of an order and any training or warranty or software licenses applicable, and/or if extended years of service coverage are available or applicable in accordance with the manufacturer’s standard commercial item practice. A fixed-price purchase order type of contract is anticipated. Inspection and acceptance will be performed at NCATS located at 9800 Medical Center Drive, Rockville, MD 20852. CAPABILITY STATEMENTS/INFORMATION SOUGHT Interested parties are expected to review this notice to familiarize itself with the requirements of this project. Failure to do so will be at your firm's own risk. Respondents must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in this announcement; (d) quantity; (e) shipping, handling, and/or installation instructions, and/or any special delivery conditions after receipt of an order. Respondents that believe that they are manufacturers or authorized re-sellers of the equipment specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; (d) quantity; (e) estimated price or cost; (f) shipping, handling, and/or installation charges; and delivery date after receipt of order. The respondent must also provide their DUNS number, organization name, address, point of contact, and size and type of business (e.g., 8(a), HubZone, etc.) pursuant to the applicable NAICS code and any other information that may be helpful in developing or finalizing the acquisition requirements. The information submitted must be in outline format that addresses each of the elements of this requirement. A cover page and an executive summary may be included but is not required. The response is limited to ten (10) pages. The 10-page limit does not include the cover page, executive summary, or references, if requested. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. Respondents must reference the subject announcement number on all correspondence related to this Small Business Sources Sought notice. The response must be submitted to Hunter Tjugum electronically, at hunter.tjugum@nih.gov, and be received prior to the closing date specified in this announcement. CONCLUDING STATEMENTS Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
75N95020Q00076 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
4/1/20, 4:47 PM